company background image
5323

Tyche Industries BSE:532384 Stock Report

Last Price

₹127.10

Market Cap

₹1.3b

7D

-11.2%

1Y

-47.6%

Updated

12 May, 2022

Data

Company Financials
532384 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends5/6

532384 Stock Overview

Tyche Industries Limited manufactures and sells active pharmaceutical ingredients and intermediates in India.

Tyche Industries Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Tyche Industries
Historical stock prices
Current Share Price₹127.10
52 Week High₹252.00
52 Week Low₹118.00
Beta0.92
1 Month Change-15.94%
3 Month Change-22.52%
1 Year Change-47.57%
3 Year Change98.59%
5 Year Change78.64%
Change since IPO2,442.00%

Recent News & Updates

Shareholder Returns

532384IN PharmaceuticalsIN Market
7D-11.2%-4.8%-5.3%
1Y-47.6%-13.1%10.9%

Return vs Industry: 532384 underperformed the Indian Pharmaceuticals industry which returned -13.1% over the past year.

Return vs Market: 532384 underperformed the Indian Market which returned 10.9% over the past year.

Price Volatility

Is 532384's price volatile compared to industry and market?
532384 volatility
532384 Average Weekly Movement8.4%
Pharmaceuticals Industry Average Movement6.8%
Market Average Movement7.0%
10% most volatile stocks in IN Market10.0%
10% least volatile stocks in IN Market4.7%

Stable Share Price: 532384 is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: 532384's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1998173Gokaraju Kumarhttps://www.tycheindustries.net

Tyche Industries Limited manufactures and sells active pharmaceutical ingredients and intermediates in India. It also provides chiral intermediates and nutraceuticals; and contract drug substance and analytical development, as well as contract manufacture services. The company primarily exports its products to the United States and Europe.

Tyche Industries Fundamentals Summary

How do Tyche Industries's earnings and revenue compare to its market cap?
532384 fundamental statistics
Market Cap₹1.30b
Earnings (TTM)₹89.32m
Revenue (TTM)₹631.79m

14.6x

P/E Ratio

2.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
532384 income statement (TTM)
Revenue₹631.79m
Cost of Revenue₹298.92m
Gross Profit₹332.87m
Other Expenses₹243.55m
Earnings₹89.32m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)8.72
Gross Margin52.69%
Net Profit Margin14.14%
Debt/Equity Ratio0.0%

How did 532384 perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

11%

Payout Ratio

Valuation

Is Tyche Industries undervalued compared to its fair value and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


29.4%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: 532384 (₹127.1) is trading below our estimate of fair value (₹180.04)

Significantly Below Fair Value: 532384 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: 532384 is good value based on its PE Ratio (14.6x) compared to the Indian Pharmaceuticals industry average (20.4x).

PE vs Market: 532384 is good value based on its PE Ratio (14.6x) compared to the Indian market (20x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 532384's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 532384 is good value based on its PB Ratio (1.3x) compared to the IN Pharmaceuticals industry average (2.6x).


Future Growth

How is Tyche Industries forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


20.4%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Tyche Industries has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Tyche Industries performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


30.9%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 532384 has high quality earnings.

Growing Profit Margin: 532384's current net profit margins (14.1%) are lower than last year (28.7%).


Past Earnings Growth Analysis

Earnings Trend: 532384's earnings have grown significantly by 30.9% per year over the past 5 years.

Accelerating Growth: 532384's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 532384 had negative earnings growth (-59.9%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (13.6%).


Return on Equity

High ROE: 532384's Return on Equity (8.9%) is considered low.


Financial Health

How is Tyche Industries's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 532384's short term assets (₹959.1M) exceed its short term liabilities (₹128.4M).

Long Term Liabilities: 532384's short term assets (₹959.1M) exceed its long term liabilities (₹28.9M).


Debt to Equity History and Analysis

Debt Level: 532384 is debt free.

Reducing Debt: 532384 has no debt compared to 5 years ago when its debt to equity ratio was 10.6%.

Debt Coverage: 532384 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 532384 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Tyche Industries's current dividend yield, its reliability and sustainability?

Dividend Score

4/6

Dividend Score 4/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


0.79%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: 532384's dividend (0.79%) is higher than the bottom 25% of dividend payers in the Indian market (0.36%).

High Dividend: 532384's dividend (0.79%) is low compared to the top 25% of dividend payers in the Indian market (1.61%).


Stability and Growth of Payments

Stable Dividend: 532384's dividends per share have been stable in the past 10 years.

Growing Dividend: 532384's dividend payments have increased over the past 10 years.


Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (11.5%), 532384's dividend payments are thoroughly covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its low cash payout ratio (16.2%), 532384's dividend payments are well covered by cash flows.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.0yrs

Average management tenure


CEO

Gokaraju Kumar (50 yo)

13.83yrs

Tenure

₹13,940,000

Compensation

Mr. Gokaraju Ganesh Kumar has been the Managing Director of Tyche Industries Ltd., since July 31, 2008 and serves as its Chairman of the Board. He served as the Chief Financial officer at Tyche Industries...


CEO Compensation Analysis

Compensation vs Market: Gokaraju's total compensation ($USD180.45K) is above average for companies of similar size in the Indian market ($USD38.81K).

Compensation vs Earnings: Gokaraju's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.


Leadership Team

Experienced Management: 532384's management team is considered experienced (3 years average tenure).


Board Members

Experienced Board: 532384's board of directors are considered experienced (5.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Tyche Industries Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Tyche Industries Limited
  • Ticker: 532384
  • Exchange: BSE
  • Founded: 1998
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: ₹1.302b
  • Shares outstanding: 10.25m
  • Website: https://www.tycheindustries.net

Number of Employees


Location

  • Tyche Industries Limited
  • H. No. C 21/A
  • Road No. 9
  • Hyderabad
  • 500096
  • India

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/12 00:00
End of Day Share Price2022/05/12 00:00
Earnings2021/12/31
Annual Earnings2021/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.